echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Can cure the new crown?

    Can cure the new crown?

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    If you talk about what is the most popular recently, "Qianjin vinesu" is on the li.
    Before, the listed companies in the traditional Chinese medicine category rose when they were "in touch", and now this "fire" is still burning in the Chinese herbal medicine mark.
     
    One price a day, the price of Chinese herbal medicine Qianjinteng doubles
     
    "The price of Qianjin vine has changed rapidly in recent da.
    " On the 17th, a relevant person in charge of a medicinal material sales company in Bozhou, Anhui told a reporter from Zhongxin Finance and Economi.
     
    "On the 13th and 14th, it was still not popular at that ti.
    The highest retail price of Qianjin rattan was 60 yuan per kilogram, and there were also 20 to 30 yuan per kilogr.
    " The person in charge said, "Today (17th) is a big de.
    Goods (from 100 kilograms) have been sold for 110 yuan a kilogram, and retail sales have reached 160 yuan a kilogr.
    "
     
    According to the person in charge, recently, many old customers are also asking about vin.
    Some people want to buy them for home cooking, and there are pharmaceutical factories to extract th.
    Some clinics and hospitals are also asking for vin.
     
    Taking into account the demand for this period of time, the person in charge predicted that the price may continue to rise in the futu.
     
    According to media reports, it was learned from relevant persons of Kangmei Traditional Chinese Medicine Network that the price of Chinese herbal medicine Qianjinteng has increased significantly recent.
    The market price has risen from 10 yuan per kilogram to more than 25 yuan per kilogram, and some drug dealers have quoted as high as 65 yuan/.
    .
     
    A reporter from China-News Finance and Economics noticed that there have been a number of pieces of information about the acquisition of Qianjinteng on some social media recent.
    Many people said, "A large number of acquisitions can be delivered to your do.

    "
     
    Why did Qianjinvine suddenly explode?
     
    According to public information, Radix chinensis is a traditional Chinese medicine in China, which belongs to the phyllophyllum family and the genus Fructus chinens.

    It is an alkaloid isolated and extracted from the tubers or vines of the genus.

    chinensis, and it is an active ingredient of Chinese herbal medici.

    It has been approved for the treatment of many disease.

     
    Previously, fenugreek was mostly used as analgesics and leukocyte proliferation drugs, which can promote the proliferation of bone marrow tissue, thereby increasing white blood cel.

     
    The recent explosion of Qianjinteng stemmed from a piece of news: On May 10, a new drug for the treatment of new crowns discovered by Chinese scientists was granted a national invention patent authorizati.

    The patent specification shows that 10 μM (micromol/L) of fenugreek inhibits the replication of coronavirus by a factor of 15,39
     
    Screenshot from the State Intellectual Property Offi.

     
    Tong Yigang, dean of the School of Life Science and Technology, Beijing University of Chemical Technology, the inventor of the patent, said that from the current research data, the drug's ability to inhibit the new coronavirus ranks high among all the new coronavirus inhibitors discovered by huma.

     
    This is not the first time that fenugreek has appeared in the public eye due to its super anti-coronavirus activi.

    As early as February 2020, fenugreek was found by Tong Yigang's team to be effective in inhibiting the new coronavir.

     
    "The report on Qianjin Phengsu was published more than two years ago, and there was no response at that ti.

    I didn't expect that the report on this patent would attract so much attention, which may be related to the current epidemic situati.

    " Tong Yigang said in a meeting on the afternoon of the 16.

    Emphasized in the live broadca.

     
    Concept stocks soared, and many companies were busy clarifying
     
      What Tong Yigang did not expect was that this report also caused a skyrocketing rise in related traditional Chinese medicine stoc.

     
      On May 13, the stocks of some Chinese medicine listed companies began to "take off", Qianjin Pharmaceutical, Bio Valley, e.

    had daily limit, and Yunnan Baiyao rose sharp.

    On May 16, after the fermentation of news related to "Qianjin Tensu" over the weekend, the stock prices of traditional Chinese medicine companies soar.

     
      However, according to the official website of the State Food and Drug Administration, there are only four domestic companies that have approval documents for Qianjintiansu tablets, namely Shenyang Guancheng Pharmaceutical, Yunnan Baiyao Group Wenshan Qihua Company, Yunnan Baiyao Group Dali Pharmaceutical and Yunnan Bio Valley Pharmaceutic.

     
      
      Screenshot from the official website of the State Food and Drug Administrati.

     
      Therefore, among these soaring stocks with "Qianjintiansu", only Bio Valley and Yunnan Baiyao do have the approval of Qianjintiansu , and many others have no related busine.

    Dali Pharmaceutical even collided with the name of Yunnan Baiyao Group Dali Pharmaceutical, and Qianjin Pharmaceutical only had the word "Qianjin" in the name, and both stocks were "Er Lianba.

     
      In the face of soaring stock prices, listed companies such as Qianjin Pharmaceutical, North China Pharmaceutical, and Buchang Pharmaceutical have successively issued clarification announcements, and some listed companies have also responded to related questions through interactive platfor.

     
      As companies have "clarified" one after another, on May 17, the performance of Qianjintansu concept stocks in the capital market diverg.

    Dali Pharmaceuticals fell by the limit, Qianjin Pharmaceuticals and Youningwei also fell, and the shares of Bio Valley and Fangsheng Pharmaceuticals continued to ri.

     
      
      Dali Pharmaceutical's daily K cha.

     
      However, some brokerage research reports still believe that under the current epidemic fermentation and the unique market environment, the attention of the new crown theme is very high, and the new crown theme that cannot be falsified in the short term at this time is worthy of attenti.

     
      However, since there are still many steps to be taken from the advent of related drugs, many people questioned that this time Qianjinsu was a "false fir.

     
      Recently, Tong Yigang also said in an interview with the media, "I also hope that this drug will complete animal experiments and clinical research as soon as possib.

    But the main problem is that this drug is not available in China, so it must be made fir.

    " (End)
      If you talk about what is the most popular recently, "Qianjin vinesu" is on the li.

    Before, the listed companies in the traditional Chinese medicine category rose when they were "in touch", and now this "fire" is still burning in the Chinese herbal medicine mark.

     
      One price a day, the price of Chinese herbal medicine Qianjinteng doubles
     
       "The price of Qianjin vine has changed rapidly in recent da.

    " On the 17th, a relevant person in charge of a medicinal material sales company in Bozhou, Anhui told a reporter from Zhongxin Finance and Economi.

     
       "On the 13th and 14th, it was still not popular at that ti.

    The highest retail price of Qianjin rattan was 60 yuan per kilogram, and there were also 20 to 30 yuan per kilogr.

    " The person in charge said, "Today (17th) is a big de.

    Goods (from 100 kilograms) have been sold for 110 yuan a kilogram, and retail sales have reached 160 yuan a kilogr.

    "
     
      According to the person in charge, recently, many old customers are also asking about vin.

    Some people want to buy them for home cooking, and there are pharmaceutical factories to extract th.

    Some clinics and hospitals are also asking for vin.

     
      Taking into account the demand for this period of time, the person in charge predicted that the price may continue to rise in the futu.

     
      According to media reports, it was learned from relevant persons of Kangmei Traditional Chinese Medicine Network that the price of Chinese herbal medicine Qianjinteng has increased significantly recent.

    The market price has risen from 10 yuan per kilogram to more than 25 yuan per kilogram, and some drug dealers have quoted as high as 65 yuan/.

    .

     
      A reporter from China-News Finance and Economics noticed that there have been a number of pieces of information about the acquisition of Qianjinteng on some social media recent.

    Many people said, "A large number of acquisitions can be delivered to your do.

    "
     
      Why did Qianjinvine suddenly explode?
     
      According to public information, Radix chinensis is a traditional Chinese medicine in China, which belongs to the phyllophyllum family and the genus Fructus chinens.

    It is an alkaloid isolated and extracted from the tubers or vines of the genus.

    chinensis, and it is an active ingredient of Chinese herbal medici.

    It has been approved for the treatment of many disease.

     
      Previously, fenugreek was mostly used as analgesics and leukocyte proliferation drugs, which can promote the proliferation of bone marrow tissue, thereby increasing white blood cel.

     
      The recent explosion of Qianjinteng stemmed from a piece of news: On May 10, a new drug for the treatment of new crowns discovered by Chinese scientists was granted a national invention patent authorizati.

    The patent specification shows that 10 μM (micromol/L) of fenugreek inhibits the replication of coronavirus by a factor of 15,39
     
    Screenshot from the State Intellectual Property Offi.

     
      Tong Yigang, dean of the School of Life Science and Technology, Beijing University of Chemical Technology, the inventor of the patent, said that from the current research data, the drug's ability to inhibit the new coronavirus ranks high among all the new coronavirus inhibitors discovered by huma.

     
      This is not the first time that fenugreek has appeared in the public eye due to its super anti-coronavirus activi.

    As early as February 2020, fenugreek was found by Tong Yigang's team to be effective in inhibiting the new coronavir.

     
       "The report on Qianjin Phengsu was published more than two years ago, and there was no response at that ti.

    I didn't expect that the report on this patent would attract so much attention, which may be related to the current epidemic situati.

    " Tong Yigang said in a meeting on the afternoon of the 16.

    Emphasized in the live broadca.

     
      Concept stocks soared, and many companies were busy clarifying
     
      What Tong Yigang did not expect was that this report also caused a skyrocketing rise in related traditional Chinese medicine stoc.

     
      On May 13, the stocks of some Chinese medicine listed companies began to "take off", Qianjin Pharmaceutical, Bio Valley, e.

    had daily limit, and Yunnan Baiyao rose sharp.

    On May 16, after the fermentation of news related to "Qianjin Tensu" over the weekend, the stock prices of traditional Chinese medicine companies soar.

     
      However, according to the official website of the State Food and Drug Administration, there are only four domestic companies that have approval documents for Qianjintiansu tablets, namely Shenyang Guancheng Pharmaceutical, Yunnan Baiyao Group Wenshan Qihua Company, Yunnan Baiyao Group Dali Pharmaceutical and Yunnan Bio Valley Pharmaceutic.

     
      
      Screenshot from the official website of the State Food and Drug Administrati.

     
      Therefore, among these soaring stocks with "Qianjintiansu", only Bio Valley and Yunnan Baiyao do have the approval of Qianjintiansu , and many others have no related busine.

    Dali Pharmaceutical even collided with the name of Yunnan Baiyao Group Dali Pharmaceutical, and Qianjin Pharmaceutical only had the word "Qianjin" in the name, and both stocks were "Er Lianba.

     
      In the face of soaring stock prices, listed companies such as Qianjin Pharmaceutical, North China Pharmaceutical, and Buchang Pharmaceutical have successively issued clarification announcements, and some listed companies have also responded to related questions through interactive platfor.

     
      As companies have "clarified" one after another, on May 17, the performance of Qianjintansu concept stocks in the capital market diverg.

    Dali Pharmaceuticals fell by the limit, Qianjin Pharmaceuticals and Youningwei also fell, and the shares of Bio Valley and Fangsheng Pharmaceuticals continued to ri.

     
      
      Dali Pharmaceutical's daily K cha.

     
      However, some brokerage research reports still believe that under the current epidemic fermentation and the unique market environment, the attention of the new crown theme is very high, and the new crown theme that cannot be falsified in the short term at this time is worthy of attenti.

     
      However, since there are still many steps to be taken from the advent of related drugs, many people questioned that this time Qianjinsu was a "false fir.

     
      Recently, Tong Yigang also said in an interview with the media, "I also hope that this drug will complete animal experiments and clinical research as soon as possib.

    But the main problem is that this drug is not available in China, so it must be made fir.

    " (End)
      If you talk about what is the most popular recently, "Qianjin vinesu" is on the li.

    Before, the listed companies in the traditional Chinese medicine category rose when they were "in touch", and now this "fire" is still burning in the Chinese herbal medicine mark.

     
      One price a day, the price of Chinese herbal medicine Qianjinteng doubles
    One price a day, the price of Chinese herbal medicine Qianjinteng doubles
     
       "The price of Qianjin vine has changed rapidly in recent da.

    " On the 17th, a relevant person in charge of a medicinal material sales company in Bozhou, Anhui told a reporter from Zhongxin Finance and Economi.

     
       "On the 13th and 14th, it was still not popular at that ti.

    The highest retail price of Qianjin rattan was 60 yuan per kilogram, and there were also 20 to 30 yuan per kilogr.

    " The person in charge said, "Today (17th) is a big de.

    Goods (from 100 kilograms) have been sold for 110 yuan a kilogram, and retail sales have reached 160 yuan a kilogr.

    "
     
      According to the person in charge, recently, many old customers are also asking about vin.

    Some people want to buy them for home cooking, and there are pharmaceutical factories to extract th.

    Some clinics and hospitals are also asking for vin.

    hospital hospital hospital
     
      Taking into account the demand for this period of time, the person in charge predicted that the price may continue to rise in the futu.

     
      According to media reports, it was learned from relevant persons of Kangmei Traditional Chinese Medicine Network that the price of Chinese herbal medicine Qianjinteng has increased significantly recent.

    The market price has risen from 10 yuan per kilogram to more than 25 yuan per kilogram, and some drug dealers have quoted as high as 65 yuan/.

    .

    medicinal herbs medicinal herbs
     
      A reporter from China-News Finance and Economics noticed that there have been a number of pieces of information about the acquisition of Qianjinteng on some social media recent.

    Many people said, "A large number of acquisitions can be delivered to your do.

    "
     
      Why did Qianjinvine suddenly explode?
      Why did Qianjinvine suddenly explode?
     
      According to public information, Radix chinensis is a traditional Chinese medicine in China, which belongs to the phyllophyllum family and the genus Fructus chinens.

    It is an alkaloid isolated and extracted from the tubers or vines of the genus.

    chinensis, and it is an active ingredient of Chinese herbal medici.

    It has been approved for the treatment of many disease.

    disease disease disease
     
      Previously, fenugreek was mostly used as analgesics and leukocyte proliferation drugs, which can promote the proliferation of bone marrow tissue, thereby increasing white blood cel.

     
      The recent explosion of Qianjinteng stemmed from a piece of news: On May 10, a new drug for the treatment of new crowns discovered by Chinese scientists was granted a national invention patent authorizati.

    The patent specification shows that 10 μM (micromol/L) of fenugreek inhibits the replication of coronavirus by a factor of 15,39
     
    Screenshot from the State Intellectual Property Offi.

     
      Tong Yigang, dean of the School of Life Science and Technology, Beijing University of Chemical Technology, the inventor of the patent, said that from the current research data, the drug's ability to inhibit the new coronavirus ranks high among all the new coronavirus inhibitors discovered by huma.

     
      This is not the first time that fenugreek has appeared in the public eye due to its super anti-coronavirus activi.

    As early as February 2020, fenugreek was found by Tong Yigang's team to be effective in inhibiting the new coronavir.

     
       "The report on Qianjin Phengsu was published more than two years ago, and there was no response at that ti.

    I didn't expect that the report on this patent would attract so much attention, which may be related to the current epidemic situati.

    " Tong Yigang said in a meeting on the afternoon of the 16.

    Emphasized in the live broadca.

     
      Concept stocks soared, and many companies were busy clarifying
      Concept stocks soared, and many companies were busy clarifying
     
      What Tong Yigang did not expect was that this report also caused a skyrocketing rise in related traditional Chinese medicine stoc.

     
      On May 13, the stocks of some Chinese medicine listed companies began to "take off", Qianjin Pharmaceutical, Bio Valley, e.

    had daily limit, and Yunnan Baiyao rose sharp.

    On May 16, after the fermentation of news related to "Qianjin Tensu" over the weekend, the stock prices of traditional Chinese medicine companies soar.

     
      However, according to the official website of the State Food and Drug Administration, there are only four domestic companies that have approval documents for Qianjintiansu tablets, namely Shenyang Guancheng Pharmaceutical, Yunnan Baiyao Group Wenshan Qihua Company, Yunnan Baiyao Group Dali Pharmaceutical and Yunnan Bio Valley Pharmaceutic.

     
      
      Screenshot from the official website of the State Food and Drug Administrati.

     
      Therefore, among these soaring stocks with "Qianjintiansu", only Bio Valley and Yunnan Baiyao do have the approval of Qianjintiansu , and many others have no related busine.

    Dali Pharmaceutical even collided with the name of Yunnan Baiyao Group Dali Pharmaceutical, and Qianjin Pharmaceutical only had the word "Qianjin" in the name, and both stocks were "Er Lianba.

    medicines medicines medicines
     
      In the face of soaring stock prices, listed companies such as Qianjin Pharmaceutical, North China Pharmaceutical, and Buchang Pharmaceutical have successively issued clarification announcements, and some listed companies have also responded to related questions through interactive platfor.

     
      As companies have "clarified" one after another, on May 17, the performance of Qianjintansu concept stocks in the capital market diverg.

    Dali Pharmaceuticals fell by the limit, Qianjin Pharmaceuticals and Youningwei also fell, and the shares of Bio Valley and Fangsheng Pharmaceuticals continued to ri.

    enterprise enterprise enterprise
     
      
      Dali Pharmaceutical's daily K cha.

     
      However, some brokerage research reports still believe that under the current epidemic fermentation and the unique market environment, the attention of the new crown theme is very high, and the new crown theme that cannot be falsified in the short term at this time is worthy of attenti.

     
      However, since there are still many steps to be taken from the advent of related drugs, many people questioned that this time Qianjinsu was a "false fir.

     
      Recently, Tong Yigang also said in an interview with the media, "I also hope that this drug will complete animal experiments and clinical research as soon as possib.

    But the main problem is that this drug is not available in China, so it must be made fir.

    " (End)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.